Home > Insider Trading > Filing (0001225208-14-003602)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
9892	Bard C R Inc	BCR	Surgical & Medical Instruments & Apparatus (3841)	221454160

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1403373	A John Deford	C/O C. R. Bard, Inc. 730 Central Avenue Murray Hill NJ 07974	Sr. Vp Sci Tech And Clin Afrs	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2014-02-04	11,252	$84.58	44,795	No	4	M	Direct
Common Stock	Acquisiton	2014-02-04	10,364	$86.15	55,159	No	4	M	Direct
Common Stock	Disposition	2014-02-04	538	$128.03	54,621	No	4	S	Direct
Common Stock	Disposition	2014-02-04	21,078	$127.51	33,543	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Option (Right to Buy)	Disposition	2014-02-04	10,364	$0.00	10,364	$86.15
Common Stock	Option (Right to Buy)	Disposition	2014-02-04	11,252	$0.00	11,252	$84.58

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2020-12-08	No	4	M	Direct
11,253		2021-12-14	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	14	Indirect	401(k) Plan

Footnotes

Represents the weighted average sales price for price increments ranging from $128 to $128.06. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
Represents the weighted average sales price for price increments ranging from $127 to $127.98. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
Includes 1.781 shares acquired under the Company's 401(k) Plan from December 10, 2013 to February 3, 2014.
Performance options granted under the 2003 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated).
Options fully vested in accordance with schedule upon achievement of certain performance criteria.
Options granted under the 2003 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated).
Of this original grant, 11,252 options are fully vested and the remaining 11,253 options will vest in two equal annual installments on 12/14/2014 and 12/14/2015.